Bridgewater Associates’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
Bridgewater Associates's IOVA Position: Q3 2026 in Review
Bridgewater Associates opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2026: 521,546 shares worth $7.73M. The stake represents 0.03% of the portfolio and ranks #455 among its holdings.
335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- Bridgewater Associates held 521,546 shares of Iovance Biotherapeutics worth $7.73M as of Q3 2026.
- Iovance Biotherapeutics was a new Bridgewater Associates position in Q3 2026.
- Iovance Biotherapeutics made up 0.03% of Bridgewater Associates's portfolio in Q3 2026, its #455 holding.
- 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on Bridgewater Associates's 13F filing for Q3 2026, filed 16 Nov 2026.